Management of tumor lysis syndrome: need for evidence-based guidelines

J Clin Oncol. 2008 Dec 1;26(34):5657-8; author reply 5658-9. doi: 10.1200/JCO.2008.19.6030. Epub 2008 Nov 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Child
  • Diuresis
  • Evidence-Based Medicine / organization & administration*
  • Humans
  • Medical Oncology / methods
  • Pediatrics / methods
  • Practice Guidelines as Topic
  • Renal Dialysis
  • Renal Insufficiency / complications*
  • Renal Insufficiency / therapy
  • Risk Factors
  • Salts / chemistry
  • Tumor Lysis Syndrome / etiology
  • Tumor Lysis Syndrome / prevention & control
  • Tumor Lysis Syndrome / therapy
  • Urate Oxidase / pharmacology

Substances

  • Antineoplastic Agents
  • Salts
  • rasburicase
  • Urate Oxidase